IFNG and hemophagocytic syndrome: These observations reinforce the concept that other mechanisms, beyond IFNγ-driven hyperinflammation, may be involved in HLH pathogenesis and suggest that the therapeutic targeting of these cytokine pathways might provide benefit in the control of the disease.